Clin2
NCT07853781Possibly a fitRecruiting

Imaging test for healthy volunteers

Healthy

This study tests a new imaging agent that could help doctors see a specific protein in the brain related to inflammation. It is only for healthy adults to see if the agent is safe and works as expected.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 105 years
Study type
Interventional

Who can take part

  • You must be 18 years or older and generally healthy.
  • You need to be able to lie flat for at least two hours for a scan.
  • You must not have a current psychiatric or mental health disorder.
  • You cannot be pregnant, breastfeeding, or have HIV.
  • You must avoid certain medications, foods, or supplements that could interfere with the study.
  • You must be willing to travel to the National Institutes of Health (NIH).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06874205Recruiting· Phase 1
Imaging a brain protein in healthy volunteers

This study tests a special imaging agent called 11C-JMJ-129 to see how it behaves in the brain and body of healthy volunteers. The goal is to better understand a brain protein called PDE4D, which may be linked to mood and anxiety disorders.

Bethesda, Maryland
NCT01399385Recruiting
New heart imaging to detect heart disease

This study tests new imaging techniques, like MRI and CT scans, to better see heart and blood vessel problems. It may help doctors find heart disease earlier and guide treatment.

Bethesda, Maryland
NCT07800481Recruiting· Early Phase 1
Imaging test for carotid artery health using a new tracer

This study tests a new imaging agent that may help see plaque buildup in the carotid arteries, which are the main arteries in the neck. It is looking for healthy volunteers to help establish a normal baseline for future scans.

St Louis, Missouri
NCT04396873Recruiting· Phase 1
PET brain scan study of inflammation markers in neurodegeneration

This Phase 1 study tests a PET scan to measure inflammation-related changes in the brain using a medication called ketoprofen. It may help researchers understand which people with certain brain diseases could benefit from treatments aimed at inflammation.

Bethesda, Maryland
NCT03331380Recruiting
Low-energy MRI study for people with or without heart disease

This study tests a special MRI method that uses lower energy exposure. It aims to improve how well researchers can scan the heart and other organs while keeping the scan as safe and comfortable as possible.

Bethesda, Maryland
NCT07457736Recruiting· Early Phase 1
Testing a new imaging agent for the brain

This study tests a new radioactive dye called [18F]GATT-44 to see how well it can show a specific brain protein on a PET scan. It may help researchers better understand brain conditions in the future.

New Haven, Connecticut

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.